Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
By onA study on Parkinson's disease links gut microbiome to brain health. Analysis of 490 PD patients and 234 controls reveals dysbiosis, microbial clusters, and disease-promoting factors in PD microbiome, offering insights for future research.
Python script used to generate the heatmap representation of identified LRRK1 phosphosites reported in doi: 10.1042/BCJ20220308
By onPython script used to generate the heatmap representation of identified high-confident LRRK1 phosphosites reported in doi: 10.1042/BCJ20220308.
Immunofluorescence assay (IFA)
By onThis protocol details the procedure of immunofluorescence assay (IFA).
Differentiation NPCs to Dopaminergic/Midbrain Neurons
By onThis protocol details methods for differentiation of NPCs to Dopaminergic/Midbrain Neurons. This protocol is part of a Collection of protocols (dx.doi.org/10.17504/protocols.io.8epv593dng1b/v1) for the paper "Glucocerebrosidase, a Parkinson´s disease-associated protein, is imported into mitochondria and regulates complex I assembly and function" (https://doi.org/10.21203/rs.3.rs-1521848/v1)
pU6-pegRNA-LRRK2-G2019S-3c
By onIt can be used to introduce LRRK2-G2019S mutation using prime editing.
Protein network analysis links the NSL complex to Parkinson’s disease via mitochondrial and nuclear biology
By onA bioinformatics approach was taken to investigate the proteome of the NSL complex, to unpick its relevance to PD progression. The authors’ data points to NSL complex members OGT and WDR5 as key drivers of this increased PD association.
Immunofluorescence Staining
By onThe protocol describes immunofluorescence staining on brain sections.
Splicing accuracy varies across human introns, tissues and age
By onThis in-depth characterization of mis-splicing can have important implications for our understanding of the role of splicing inaccuracies in human disease and the interpretation of long-read RNA-sequencing data.
fcs files to “The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model”
By onDataset associated with DOI: 10.17617/3.51VXU0
Purification of recombinant TauRD from E. coli
By onThe protocol outlines procedures for studying Tau protein aggregation in vitro using ThT fluorescence measurements.
A Single-Cell Atlas of Cell Types, States, and Other Transcriptional Patterns from Nine Regions of the Adult Mouse Brain
By onWe report 690K single-cell transcriptomes from nine different brain regions from adult mice (Frontal and Posterior Cortex, Hippocampus, Thalamus, Cerebellum, Striatum, Globus Pallidus externus/Nucleus Basalis, Entopeduncular / Subthalamic Nuclei, & Substantia Nigra / Ventral Tegmental Area).
HEK293 TMEM192-HA ::mNEON-YIPF4
By onHEK293 TMEM192-HA ::mNEON-YIPF4 HEK293::TMEM192-3xHA::mNEON-YIPF4 PubMed=37757899; Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line). Characteristics: Using CRISPR/Cas9 YIPF4 was N-terminally tagged on both alleles with mNeonGreen (PubMed=37757899). Transfected with: UniProtKB; A0A1S4NYF2; mNeonGreen (derivative of Branchiostoma lanceolatum blFP-Y3). Transformant: NCBI_TaxID; 28285; Adenovirus 5. Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. NCBI_TaxID=9606; ! Homo sapiens (Human) RRID:CVCL_C0I5 ! HEK293::TMEM192-3xHA Female Fetus Transformed cell line
Expression and purification protocol of ULK1 Complex wt or K46I mutant
By onThis Protocol describes the expression and purification of ULK1 Complex wt or K46I mutant.
In situ architecture of neuronal α-Synuclein inclusions
By onAlpha-synuclein aggregation has been associated with Parkinson’s disease. Using cutting-edge imaging tools, the authors show neuronal alpha-synuclein inclusions within their native states.
pBPK1520-SNCA-A30P-ng
By onIt can be used to introduce SNCA-A30P mutation using prime editing, PE3 approach.
In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
By onUsing a newly developed rodent model, the authors assessed whether the intracellular buildup of neuromelanin that occurs with age can be slowed down in vivo to prevent or attenuate Parkinson’s disease.
